Immutep LTD ADR buy Mori8
Start price
20.09.16
/
50%
€2.62
Target price
27.09.16
€3.60
Performance (%)
0.00%
End price
27.09.16
€2.62
Summary
This prediction ended on 27.09.16 with a price of €2.62. The BUY prediction by Mori8 closed unchanged from the start price. Mori8 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immutep LTD ADR | 7.879% | 7.879% | -73.824% | -80.000% |
| iShares Core DAX® | -1,36 % | -2,16 % | 2,08 % | 52,68 % |
| iShares Nasdaq 100 | -3,70 % | -1,16 % | 32,60 % | 88,75 % |
| iShares Nikkei 225® | -2,51 % | 7,93 % | 58,27 % | 82,31 % |
| iShares S&P 500 | -1,66 % | -0,70 % | 22,96 % | 66,08 % |
Comments by Mori8 for this prediction
In the thread Immutep LTD ADR diskutieren
Das Unternehmen konzentriert sich auf die Immuntherapie von Krebs-Forschung.
Brokers have set a twelve-month consensus target price of $5.00 for the company, according to Zacks.